Takuro Kuriyama

发表

Clinical Features and Treatment Outcomes of 51 Patients with Chronic Myeloid Leukemia Treated with a Tyrosine Kinase Inhibitor at a Single Institution from 2002 to 2014.

F. Ishikawa, H. Ochiai, K. Shimoda, 2016, Journal of clinical and experimental hematopathology : JCEH.

The BALB/c-specific polymorphic SIRPA enhances its affinity for human CD47, inhibiting phagocytosis against human cells to promote xenogeneic engraftment.

K. Akashi, H. Iwasaki, K. Takenaka, 2014, Experimental hematology.

JAK2 V617F uses distinct signalling pathways to induce cell proliferation and neutrophil activation

K. Akashi, K. Takenaka, T. Miyamoto, 2010, British journal of haematology.

Diffuse panbronchiolitis after humanized anti-CCR4 monoclonal antibody therapy for relapsed adult T-cell leukemia/lymphoma

K. Akashi, H. Iwasaki, K. Takenaka, 2013, International Journal of Hematology.

Outcomes of allogeneic stem cell transplantation for patients with hematologic diseases ≥60 years old

T. Shima, T. Eto, T. Kuriyama, 2023, Blood cell therapy.

Successful Secondary Umbilical Cord Blood Transplantation for Graft Failure in Acute Myelogenous Leukemia, Treated with Modified One-Day Conditioning Regimen, and Graft-Versus-Host Disease Prophylaxis Consisting of Mycophenolate and Tacrolimus.

K. Takenaka, A. Takami, S. Yoshida, 2015, Journal of clinical and experimental hematopathology : JCEH.

Efficacy of prophylactic letermovir for cytomegalovirus reactivation in hematopoietic cell transplantation: a multicenter real-world data

K. Akashi, K. Takenaka, T. Miyamoto, 2020, Bone Marrow Transplantation.

Different risk factors related to adenovirus- or BK virus-associated hemorrhagic cystitis following allogeneic stem cell transplantation.

K. Akashi, H. Iwasaki, K. Takenaka, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Clinical Features and Treatment Outcomes of Hematopoietic Stem Cell Transplantation During 2006-2016 at a Single Institution in Miyazaki Prefecture

K. Akashi, T. Miyamoto, Y. Mori, 2019, Journal of Hematopoietic Cell Transplantation.

Clinical features and outcomes of 9 patients with immunodeficiency-associated lymphoproliferative disorders treated at a single institution.

K. Oshima, S. Inoue, S. Yoshida, 2014, Journal of clinical and experimental hematopathology : JCEH.

Successful treatment of immunodeficiency-associated EBV-negative lymphoproliferative disorders in rheumatoid arthritis by methotrexate withdrawal and prevention of its relapse by rituximab administration.

S. Yoshida, Y. Shimao, K. Beppu, 2012, Journal of clinical and experimental hematopathology : JCEH.

Engulfment of hematopoietic stem cells caused by down-regulation of CD47 is critical in the pathogenesis of hemophagocytic lymphohistiocytosis.

K. Akashi, H. Iwasaki, K. Takenaka, 2012, Blood.

Heterogeneous impact of cytomegalovirus reactivation on nonrelapse mortality in hematopoietic stem cell transplantation.

J. Kanda, K. Ohashi, K. Ikegame, 2020, Blood advances.

Sequential Organ Failure Assessment (SOFA) score as a prognostic factor for disseminated intravascular coagulation patients with infectious disease treated with recombinant human soluble thrombomodulin (rhTM) in clinical practice

H. Ochiai, K. Shimoda, S. Yoshida, 2017 .

Effects of recombinant human soluble thrombomodulin treatment for disseminated intravascular coagulation at a single institution--an analysis of 62 cases caused by infectious diseases and 30 cases caused by hematological diseases.

H. Moritake, H. Ochiai, K. Shimoda, 2014, Internal medicine.

Outcome predictors after retransplantation in relapsed acute lymphoblastic leukemia: a multicenter, retrospective study

K. Akashi, T. Miyamoto, Y. Mori, 2020, Annals of Hematology.

Therapeutic modality of 11 patients with TTP in a single institution in Miyazaki from 2000 to 2011.

M. Matsumoto, Y. Fujimura, S. Yoshida, 2013, Internal medicine.

CHOP Plus Sequential Mogamulizumab As First-Line Therapy for Untreated Adult T-Cell Leukemia-Lymphoma

K. Akashi, T. Miyamoto, R. Suzuki, 2021, Blood.

Previous exposure to bortezomib is linked to a lower risk of engraftment syndrome after autologous hematopoietic stem cell transplantation

K. Akashi, H. Iwasaki, K. Takenaka, 2019, Leukemia & lymphoma.

Secondary Skin Cancer in a Case with Long-term Voriconazole after Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia

K. Takenaka, Y. Mori, H. Ochiai, 2022, Internal medicine.

Cytomegalovirus gastroenteritis in patients with acute graft-versus-host disease

H. Nakasone, S. Kimura, Y. Kanda, 2021, Blood advances.

Risk and predictive factors for candidemia after allogeneic hematopoietic cell transplantation: JSTCT Transplant Complications Working Group

H. Nakasone, S. Kimura, Y. Kanda, 2022, Transplantation and Cellular Therapy.

Improved trends in survival and engraftment after single cord blood transplantation for adult acute myeloid leukemia

Takafumi Kimura, M. Onizuka, Satoshi Takahashi, 2022, Blood Cancer Journal.

HLA 1–3 antigen‐mismatched related peripheral blood stem cells transplantation using low‐dose antithymocyte globulin versus unrelated cord blood transplantation

J. Kanda, Takafumi Kimura, M. Okabe, 2022, American journal of hematology.

Long-term remission after high-dose chemotherapy followed by auto-SCT as consolidation for intravascular large B-cell lymphoma

K. Akashi, K. Ohshima, T. Miyamoto, 2014, Bone Marrow Transplantation.

Two cases of primary adult T-cell leukemia/lymphoma of bone: case reports and a review of the literature

K. Yamashita, N. Kawano, T. Kuriyama, 2016, International Journal of Hematology.

Prognostic impact of complex and/or monosomal karyotypes in post‐transplant poor cytogenetic acute myeloid leukaemia: A quantitative approach

M. Onizuka, T. Kondo, T. Ichinohe, 2023, British journal of haematology.

Clinical effect of rituximab as early administration for refractory thrombotic thrombocytopenic purpura associated with connective tissue diseases

F. Ishikawa, M. Matsumoto, K. Shimoda, 2018 .

Engulfment of hematopoietic stem cells caused by down-regulation of CD47 is critical in the pathogenesis of hemophagocytic lymphohistiocytosis.

K. Akashi, H. Iwasaki, K. Takenaka, 2012, Blood.

Portal vein thrombosis during eltrombopag treatment for immune thrombocytopenic purpura in a patient with liver cirrhosis due to hepatitis C viral infection.

T. Kawaguchi, M. Sata, K. Nagata, 2013, Journal of clinical and experimental hematopathology : JCEH.

Impact of HLA-mismatched unrelated transplantation in patients with adult T-cell leukemia/lymphoma

J. Kanda, Y. Mori, K. Imada, 2023, Bone Marrow Transplantation.

Successful treatment of Rituximab-resistant Epstein-Barr virus-associated post-transplant lymphoproliferative disorder using R-CHOP.

K. Yamashita, N. Kawano, T. Kuriyama, 2014, Journal of clinical and experimental hematopathology : JCEH.

Successful allogeneic stem cell transplantation in a case with acute myeloid leukemia and invasive Schizophyllum commune rhinosinusitis.

K. Akashi, K. Takenaka, T. Miyamoto, 2020, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Successful surgical treatment for pulmonary crystal-storing histiocytosis following the onset of gastric non-hodgkin lymphoma.

K. Oshima, H. Masuyama, S. Yoshida, 2013, Journal of clinical and experimental hematopathology : JCEH.

The Confirmation of Safety for the Intensified Conditioning Regimens: A Retrospective Study of Allogeneic Hematopoietic Stem Cell Transplantation for Non-Remission Hematological Malignant Diseases

T. Iino, H. Henzan, N. Saito, 2018, International journal of hematology-oncology and stem cell research.

Fludarabine plus reduced-intensity busulfan versus fludarabine plus myeloablative busulfan in patients with non-Hodgkin lymphoma undergoing allogeneic hematopoietic cell transplantation

M. Onizuka, Y. Atsuta, E. Kondo, 2023, Annals of Hematology.

Clinical features and treatment outcomes of six patients with disseminated intravascular coagulation resulting from acute promyelocytic leukemia and treated with recombinant human soluble thrombomodulin at a single institution.

H. Ochiai, S. Yoshida, K. Yamashita, 2013, Internal medicine.